¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"brain gut peptide"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
¿µ¹® brain stem ÇÑ±Û ³úÁÙ±â
¼³¸í   
  ³úÁÙ±âÀ̶õ ´ë³ú¿Í Ã´¼ö¸¦ À̾îÁִ ´Ù¸® ¿ªÇÒÀ» Çϴ ³úÀÇ ºÎºÐÀ¸·Î À̰÷¿¡´Â Áß°£³ú, ´Ù¸®³ú, ¼û³úÀÇ 3°³ÀÇ ºÎºÐÀÌ Æ÷ÇԵȴÙ. À̰÷Àº ´ë³ú¿¡¼­ ³ª°¡´Â ¿îµ¿½Å°æ°ú ´ë³ú·Î µé¾î¿À´Â °¨°¢½Å°æÀÇ Áß¿äÇÑ Åë·Î°¡ Àִ °÷À̸ç, µ¿½Ã¿¡ ´ëºÎºÐÀÇ ³ú½Å°æ(ô¼ö¸¦ °ÅÄ¡Áö ¾Ê°í ³ª°¡´Â ½Å°æ, Áï ³ú¿¡¼­ Á÷Á¢ ³ª¿À°í µé¾î¿À´Â ½Å°æÀ» À̸£´Â ¸»)ÀÇ Áß¿äÇÑ ¿äÁöÀÌ´Ù.
¿µ¹® blood-brain barrier(BBB) ÇÑ±Û Ç÷³úÀ庮
¼³¸í   
  ³ú¿Í Ã´¼ö¿¡´Â Ç÷·ù·ÎºÎÅÍ ¾î¶² ¹°ÁúÀÌ À¯ÀԵǴ °ÍÀ» ¸·´Â À庮ÀÌ´Ù. À̰ÍÀº ³ú¿Í Ã´¼ö¿¡ Á¸ÀçÇϴ ¸ð¼¼Ç÷°üÀÇ Åõ°ú¼ºÀÌ ºñ±³Àû ´Ù¸¥ ¸ð¼¼Ç÷°üÀÇ Åõ°ú¼ºº¸´Ù ¶³¾îÁö±â ¶§¹®ÀÌ´Ù.
¿µ¹® blood-brain barrier ÇÑ±Û Ç÷¾×³úÀ庮
¼³¸í   
  Ç÷¾×À¸·ÎºÎÅÍ ³ú·Î´Â ÁöÁú¿ëÇØ¼ºÀÌ ³ôÀº ¾à¹°¹Û¿¡ ÀÌÇàµÇÁö ¾Ê´Â´Ù. ¼ö¿ë¼ºÀÇ ¾à¹°À» ³ú·Î ÀÌÇàµÇÁö ¾Ê°Ô Çϰí Àִ °ÍÀÌ Ç÷¾×³úÀ庮À̸砳úÀÇ ¸ð¼¼Ç÷°ü ³»ÇǼ¼Æ÷, ¸ð¼¼Ç÷°ü ÁÖÀ§ÀÇ ¼¼Æ÷°¡ À庮ÀÌ µÇ°í ÀÖ´Ù. ¹°Áú±³È¯Àº ¼öµ¿È®»ê¿¡ ÀÇÇØ ÀÌ·ç¾îÁöÁö¸¸, ³úÀÇ »ý¸®Àû È°µ¿¿¡ ÇÊ¿äÇÑ ¹°ÁúÀº ÀÌ¿ÂÇüÀ̶󵵠´ãü¸¦ ÅëÇØ ÀÌÇàµÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • acute brain syndrome
    ±Þ¼º³úÁõÈıº
  • blood-brain barrier
    Ç÷¾×³úÀ庮
  • brain
    ³ú
  • brain abscess
    ³ú°í¸§Áý, ³ú³ó¾ç
  • brain CT
    ³úÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(¼ú)
  • brain death
    ³ú»ç
  • brain death syndrome
    ³ú»çÁõÈıº
  • brain infarct
    ³ú°æ»ö
  • brain mapping
    ³úÁöµµÈ­
  • brain scan
    ³ú½ºÄµ
  • brain stem
    ³úÁÙ±â, ³ú°£
  • brain stem evoked potential
    ³úÁÙ±âÀ¯¹ßÀüÀ§
  • brain stem evoked response audiometry
    ³úÁÙ±âÀ¯¹ß¹ÝÀÀû·Â°Ë»ç
  • brain stem glioma
    ³úÁÙ±â½Å°æ¾Æ±³Á¾, ³ú°£±³Á¾
  • brain stem reflex
    ³úÁÙ±â¹Ý»ç, ³ú°£¹Ý»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • brain death
    ³ú»ç
  • brain infarct
    ³ú°æ»ö
  • brain map
    ³úÁÂÇ¥µµ
  • brain stem
    ³úÁÙ±â
  • brain vesicle
    ³ú¼ÒÆ÷
  • brain death syndrome
    ³ú»çÁõÈıº
  • brain function mapping
    ³ú±â´ÉÁöµµÈ­
  • brain stem evoked potential
    ³úÁÙ±âÀ¯¹ßÀüÀ§
  • olfactory brain
    Èİ¢³ú
  • minimal brain dysfunction
    °æ¹Ì³ú±â´ÉÀå¾Ö, ¹Ì¼Ò³ú±â´ÉÀå¾Ö
  • minor brain damage
    °æµµ³ú¼Õ»ó
  • elective brain irradiation
    ¿¹¹æ³úÁ¶»ç
  • hypoxic brain injury
    Àú»ê¼Ò³ú¼Õ»ó
  • organic brain syndrome
    ±âÁú³úÁõÈıº
  • primary brain vesicles
    ÀÏÂ÷³úÆ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hind gut
    µÚÀå°ü, ÈÄÀå.
  • hind gut
    ÈÄÀå(ÈÄÀå).
  • immunity, gut
    Àå°ü¸é¿ª
  • primitive gut
    ¿ø½ÃÀå°ü, ¿ø½ÃÀå(ê«ã· ).
  • Glutamine, brain producing
    ±Û·çŸ¹Î, ³úÇü¼º(Òàû¡à÷)
  • acervulus cerebri =brain sand
    ³ú»ç(ÒàÞã).
  • acute brain disorder
    ±Þ¼º ³úÀå¾Ö (¡­Òàî¡äô).
  • acute brain syndrome
    ±Þ¼º ³úÁõÈıº(¡­Òàñøý¦ÏØ).
  • arachnoid of brain
    ³ú°Å¹Ì¸·
  • functional brain imaging
    ±â´ÉÀû ³ú¿µ»ó
  • pia mater of brain
    ³ú¿¬Áú¸·
  • primary brain vesicles
    ÀÏÂ÷³úÆ÷(¡­Òàøà).
  • prolapse of brain
    ³úÅ»(ÃâÁõ)(Òà÷­õóñø).
  • prolapse of brain
    ³úÅ»(ÃâÁõ)(Òà÷­(õóñø))
  • prosencephalon =fore brain
    Àü³ú.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • short gut syndrome
    ´ÜÀåÁõÈıº.
  • short gut syndrome
    ´ÜÀåÁõÈıº.
  • short gut syndrome
    ´ÜÀåÁõÈıº(Ó­íóñøý¦ÏØ)
  • silkworm gut
    °ß»ç(°ß»ç), (ºÀÇÕ¿ë(ºÀÇÕ¿ë) .
  • uro-gut
    ºñ´¢Ã¢ÀÚ
  • atrial natriuretic peptide
    ½É¹æ³ªÆ®·ýÀÌ´¢ÆéŸÀ̵å, ½É¹æ³ªÆ®·ýÀÌ´¢ÆéƼµå
  • c-peptide
    ¾¾-ÆéŸÀ̵å, ¾¾-ÆéƼµå
  • c-peptide
    c ÆéƼµå
  • c-peptide measurement
    c ÆéƼµåÃøÁ¤
  • calcitonin-gene related peptide
    Ä®½ÃÅä´ÑÀ¯ÀüÀÚ°ü·ÃÆéƼµå
  • endogenous opiate peptide
    ³»À缺 ¿ÀÇÇ¿¡ÀÌÆ® ÆéŸÀ̵å, ³»À缺 ¾ÆÆí¾ç ÆéŸ À̵å.
  • neuro-peptide
  • opioid peptide
    ¾ÆÆí¾çÆéƼµå<ÆéŸÀ̵å>.
  • opioid peptide
    ¾ÆÆíÀ¯»çÆéƼµå<ÆéŸÀ̵å>.
  • parathyroid hormone-related peptide
    ºÎ°©»ó¼±(ÜùË£ßÒàÍ)È£¸£¸ó¿¬°ü(¡­æáμ)ÆéŸÀ̵å
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • peptide antibiotic
    ÆéŸÀ̵å Ç×»ýÁ¦(ù÷ßæð¥)
  • peptide bond
    ÆéŸÀÌµå °áÇÕ(Ì¿ùê)
  • peptide hormone
    ÆéŸÀ̵å È£¸£¸ó
  • peptide map
    ÆéŸÀ̵å Áöµµ(ò¢Óñ)
  • peptide synthetase
    ÆéŸÀÌµå ½ÅÅ×Å×À̽º
  • phosphate acceptor peptide
    Àλê¼ö¿ë(×òß«áôé») ÆéŸÀ̵å
  • signal peptide
    ½ÅÈ£(ãáûÜ)ÆéŸÀ̵å
  • S peptide
    S ÆéŸÀ̵å
  • spore peptide
    Æ÷ÀÚ(øàí­)
  • streptogenin peptide
    ½ºÆ®·¾ÅäÁ¦´Ñ ÆéŸÀ̵å
  • tryptic peptide
    Æ®¸³½ÅºÐÇØ(ÝÂú°) ÆéŸÀ̵å
  • vasoactive intestinal peptide
    Ç÷°ü ÀÛµ¿¼º(úìηíÂÔÑàõ) Àå(íó)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
GA Gamblers Anonymous; gastric analysis; gastric antrum; general anesthesia; general angiography; gener...
GALT galactose-1-p-uridyltransferase; gut-associated lymphoid tissue
GML gut mucosa lymphocyte
IG immature granule; immunoglobulin; insulin and glucose; intragastric; irritable gut
SWG silkworm gut; standard wire gauge
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
BNP Brain natriuretic peptide
hBNP Human brain natriuretic peptide
pBNP Porcine brain natriuretic peptide
C-peptide connecting peptide
ABI Acquired Brain Injury
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • precursor peptide
    Àü±¸ ÆéƼµå
  • proenkephalin peptide
    ÇÁ·Î ¿£ÄÉÆÈ¸° ÆéƼµå
  • proenkephalin-derived peptide
    ÇÁ·Î¿£ÄÉÆÈ¸° À¯·¡ ÆéƼµå
  • signal peptide
    ½ÅÈ£ ÆéƼµå
  • simple-chain peptide

    simplex (´Ü¼ø

  • single peptide
    ´ÜÀÏ ÆéŸÀ̵å
  • acute brain disorder
    ±Þ¼º ³úÀå¾Ö
  • atypical or mixed organic brain syndrome
    ºñÁ¤Çü ³»Áö È¥ÇÕÇü ±âÁú¼º ³ú ÁõÈıº
  • blood-brain barrier
    Ç÷³ú À庮
    ³ú¿Í ô¼ö¿¡´Â Ç÷·ù·ÎºÎÅÍ ¾î¶² ¹°ÁúÀÌ À¯ÀԵǴ °ÍÀ» ¸·´Â À庮ÀÌ Á¸ÀçÇϰí À̰ÍÀ» Ç÷³ú À庮À̶ó ÇÑ´Ù. À̰ÍÀº ³ú¿Í ô¼ö¿¡ Á¸ÀçÇÏ´Â ¸ð¼¼Ç÷°üÀÇ Åõ°ú¼ºÀÌ ´Ù¸¥ ¸ð¼¼Ç÷°ü¿¡ ºñÇØ ¶³¾îÁö±â ¶§¹®ÀÌ´Ù.
  • brain abscess
    ³ú ³ó¾ç
    ³ú ³ó¾çÀº ³ú ½ÇÁú³»¿¡ ¿©·¯ Á¾·ùÀÇ ¼¼±Õ, Áø±Õ, ¿øÃæ·ùµéÀÇ °¨¿°¿¡ ÀÇÇÏ¿© ¹ß»ýµÇ´Â ±¹ÇÑµÈ È­³ó¼º ÁúȯÀÌ´Ù. 1. ¿øÀÎ : ¿©·¯ Á¾·ùÀÇ ¼¼±Õ, Áø±Õ, È¿¸ð±Õ, ±â»ýÃæ µîÀÌ ³ú ³ó¾çÀ» ÀÏÀ¸Å³ ¼ö ÀÖÀ¸¸ç, °ú°Å¿¡´Â ¿¬¼â»ó ±¸±Õ, Æ÷µµ»ó ±¸±Õ, Àå³»±Õ, Æó·Å ±¸±Õ µîÀÌ °¡Àå ÈçÇÑ ¿øÀαÕÀ̾úÀ¸³ª ±Ù·¡¿¡ ¿Í¼­ Ç×»ýÁ¦ÀÇ ±¤¹üÀ§ÇÑ »ç¿ë, ¸é¿ª°áÇÌÁõ ȯÀÚÀÇ Áõ°¡ µîÀ¸·Î ¼Ò °£±Õ, Çø±â¼º ¿¬¼â»ó ±¸±ÕÀÌ °¡Àå ÈçÇÑ ¿øÀαÕÀ¸·Î µÇ¾úÀ¸¸ç, Nocardia±Õ, Áø±Õ, ±â»ýÃæÀÇ ºóµµµµ ³ô¾ÆÁö°í ÀÖ´Ù. °¨¿° °æ·Î¸¦ º¸¸é ÁßÀÌ¿°À̳ª ºÎºñµ¿¿°¿¡¼­ Á÷Á¢ ¶Ç´Â ³ú ÇÇÁú, ³ú°æ¸·ÀÇ Á¤¸ÆÀ» ÅëÇÏ¿© °¨¿°µÇ°Å³ª µÎºÎÀÇ °üÅë»óÀ̳ª µÎºÎ ¼ö¼úÈÄÀÇ ÇÕº´ÁõÀ¸·Î Ç÷·ù¸¦ ÅëÇÑ ÆÐÇ÷¼º »öÀüÀ» ÅëÇÏ¿© ¶Ç´Â ¾Æ±Þ¼º ¼¼±Õ¼º ½É³»¸·¿°À̳ª ¼±Ãµ¼º ½ÉÀ庴 ±×¸®°í ¸é¿ª±â´ÉÀÌ ÀúÇÏµÈ °æ¿ì¿¡ ÁÖ·Î ¹ß»ýÇϸç, »ó´ç¼ö¿¡¼­´Â °¨¿° °æ·Î¸¦ ¸ð¸£´Â °æ¿ìµµ ÀÖ´Ù. 2. Áõ»ó : ´ëºÎºÐÀÇ ³ú ³ó¾çÀº 20¼¼ ÀÌÀü¿¡ ¹ß»ýµÇ´Âµ¥ ±× ÀÌÀ¯´Â ÀÌ ¿¬·É ±º¿¡¼­ ÁßÀÌ¿°À̳ª Ãà³óÁõÀÇ ºóµµ°¡ ³ôÀ¸¸ç, ¼±Ãµ¼º ½ÉÀ庴¿¡ ±âÀÎµÈ ³ú ³ó¾çÀÌ ÁÖ·Î ¼Ò¾Æ±â¿¡ ¹ß»ýµÇ±â ¶§¹®ÀÌ´Ù. 3´ë 2¿¡¼­ 2´ë 1ÀÇ ºñÀ²·Î ³²ÀÚ¿¡¼­ ¸¹ÀÌ ¹ß»ýÇÑ´Ù. ÁßÀÌ¿°¿¡¼­ ¹ß»ýµÈ °æ¿ì¿¡´Â ÁÖ·Î ÃøµÎ¿±¿¡ ¹ß»ýµÇ¸ç °¡²û ÃøµÎ¿±À̳ª ÅÍŰ¾È¿¡µµ »ý±ä´Ù. Ç÷¾×À» ÅëÇÏ¿© ÀüÀÌµÈ °æ¿ì°¡ ÃÖ±Ù Áõ°¡µÇ°í Àִµ¥ ´ëºÎºÐ ´Ù¹ß¼ºÀ̰ųª ±íÀº °÷¿¡ À§Ä¡Çϰí óÀ½ Áø´Ü ½Ã °æ°è°¡ È®½ÇÄ¡ ¾ÊÀº Ư¡ÀÌ ÀÖ¾î ¿¹Èİ¡ ÁÁÁö ¾ÊÀº ÆíÀÌ´Ù. ÁÖ Áõ»óÀ̳ª ½Å°æÇÐÀû ÀÌ»ó Á¤µµ´Â ³ó¾çÀÇ ºÎÀ§, Å©±â, º´¼ÒÀÇ ¼ö, ¿øÀαÕÀÇ µ¶¼º, ÁÖº¯ ³ú ºÎÁ¾ÀÇ Á¤µµ, °¨¿°¿¡ ´ëÇÑ ¼÷ÁÖÀÇ ¹ÝÀÀ µî¿¡ µû¶ó ´Ù¸£¸ç ÀϹÝÀûÀ¸·Î ³ú Á¶Á÷ÀÇ ÆÄ±«¿Í Á¾±« È¿°ú¿¡ µû¶ó µÎ°³°­ ³»¾ÐÀÇ »ó½Â°ú ±¹¼Ò¼º ½Å°æÇÐÀû Àå¾Ö¸¦ ÀÏÀ¸Å²´Ù. Áõ»ó ¹ßÇö°ú Áø´Ü±îÁöÀÇ ±â°£Àº 75%¿¡¼­ 2ÁÖ À̳»ÀÌ¸ç °¡Àå ÈçÇÑ Áõ»óÀº Á¡Â÷ ½ÉÇØÁö´Â µÎÅëÀ¸·Î 70-95%ÀÇ È¯ÀÚ¿¡¼­ ³ªÅ¸³ª¸ç ÁÖ·Î ¿À½É°ú ±¸Å並 µ¿¹ÝÇÑ´Ù. ¹ßÀÛÀÌ 30-50%ÀÇ È¯ÀÚ¿¡¼­ ³ªÅ¸³ª°í ¹Ý¼öÀÇ È¯ÀÚ¿¡¼­ ¹Ì¿­ÀÌ ³ªÅ¸³ªÁö¸¸ 39µµ ÀÌ»óÀÇ °í¿­Àº µå¹°´Ù. ¼Ò³ú ³ó¾çÀÇ °æ¿ì¿¡´Â Çö±âÁõÀ̳ª ÇöÈÆÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù. ÀÔ¿ø½Ã ¾à ¹Ý¼öÀÇ È¯ÀÚ¿¡¼­´Â ¹ß¿­ µîÀÇ Àü½Å Áõ»óÀÌ ³ªÅ¸³ª¸ç µÎ°³°­ ³»¾ÐÀÇ »ó½ÂÀ¸·Î 23-50%¿¡¼­ À¯µÎ ºÎÁ¾À» º¼ ¼ö ÀÖ´Ù. ÀÔ¿ø ½Ã¿¡ ¹Ý¼ö À̻󿡼­ ÀÇ½Ä Àå¾Ö°¡ ÀÖÀ¸¸ç °æÇÑ ÀǽÄÀÇ Àå¾Ö·ÎºÎÅÍ È¥¼ö »óűîÁö ¿©·¯ Á¤µµ·Î ³ªÅ¸³­´Ù. óÀ½ ÀǽÄÀÇ Á¤µµ°¡ ȯÀÚÀÇ ¿¹ÈÄ¿¡¼­ °¡Àå Áß¿äÇÏ´Ù. ³ú ÇÇÁúÀ̳ª ³ú ÇÇÁú ÇϺÎÀÇ Æ¯Á¤ÇÑ ºÎÀ§ÀÇ ¼Õ»óÀ¸·Î ±¹¼Ò¼º ½Å°æÇÐÀû Àå¾Ö¸¦ ÀÏÀ¸Å³ ¼ö ÀÖÀ¸¸ç ¹Ý½Å ¸¶ºñ, ¾ð¾îÀå¾Ö, ½Ã¾ß °á¼Õ µîÀ» ÈçÈ÷ º¼ ¼ö ÀÖ´Ù. ¼Ò³ú ³ó¾çÀÇ °æ¿ì¿¡´Â ¼öÆò¼º ¾È±¸ ÁøÅÁ
  • brain center
    ´ë³ú ÁßÃß
  • brain concussion
    ³úÁøÅÁ
    µÎºÎ¿¡ °­ÇÑ ¿Ü·ÂÀÌ ÀÛ¿ëÇÑ Á÷ÈÄ¿¡ ÀϾ´Â Áõ¼¼. µÎºÎ¿¡ ¿Ü·ÂÀÌ ÀÛ¿ëÇÔ°ú µ¿½Ã¿¡ Àϰú¼ºÀÇ ÀÇ½Ä ¼Ò½ÇÀ» ÀÏÀ¸Å°Áö¸¸ ³ú ½ÇÁúÀÇ ÆÄ±«´Â ÀϾÁö ¾ÊÀº »óÅÂÀÌ´Ù. ´Ü½Ã°£
  • brain damage
    ³ú ¼Õ»ó
  • brain death syndrome
    ³ú»ç ÁõÈıº
  • brain function mapping
    ³ú ±â´É ÁöµµÈ­
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
vasoactive intestinal peptide <gastroenterology, protein> Peptide of 28 amino acids, originally isolated from porcine intestine, but later found in the central nervous system where it acts as a neuropeptide and is released by specific interneurons. May also affect behaviour of cells of the immune system.
Acronym: VIP
(05 Jan 1998)
gastrin-releasing peptide <hormone> A regulatory peptide (27 amino acids) thought to be the mammalian equivalent of bombesin. It elicits gastrin release and regulates gastric acid secretion and motor function.
It causes bronchoconstriction and vasodilation in the respiratory tract and stimulates the growth and mitogenesis of cells in culture. Once released from nerves in the antrum of the stomach, the neuropeptide stimulates release of gastrin from the g cells.
Chemical name: Gastrin-releasing peptide
(12 Dec 1998)
receptors, calcitonin gene-related peptide Cell surface proteins that bind calcitonin gene-related peptide (cgrp) with high affinity and trigger intracellular changes which influence the behaviour of cells. Cgrp receptors are present in both the central nervous system and the periphery and are not the same as calcitonin receptors.
(12 Dec 1998)
receptors, invertebrate peptide Cell surface receptors for invertebrate peptide hormones or neuropeptides.
(12 Dec 1998)
receptors, peptide Cell surface receptors that bind peptide messengers with high affinity and regulate intracellular signals which influence the behaviour of cells.
(12 Dec 1998)
receptors, vasoactive intestinal peptide Cell surface proteins that bind vasoactive intestinal peptide (vip) with high affinity and trigger intracellular changes which influence the behaviour of cells.
(12 Dec 1998)
glutaminyl-peptide cyclotransferase <enzyme> Catalyses the formation of 5-oxoprolyl-trna and nh3 from l-glutaminyl-trna; also acts on glutaminyl peptides
Registry number: EC 2.3.2.5
Synonym: glutaminyl cyclase, glutaminylpeptide cyclase, glutamine cyclotransferase, glutaminyl-trna cyclotransferase
(26 Jun 1999)
peptide <biochemistry> A compound of two or more amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another.
(27 Sep 1997)
peptide antibiotic lactonase <enzyme> Peptide lactone and water gives linear peptide
Registry number: EC 3.1.1.-
(26 Jun 1999)
peptide bond The amide linkage between the carboxyl group of one amino acid and the amino group of another. The linkage does not allow free rotation and can occur in cis or trans configuration, the latter the most common in natural peptides, except for links to the amino group of proline, which are always cis.
(18 Nov 1997)
peptide chain elongation The process whereby an amino acid is joined through a substituted amide linkage to a chain of peptides.
(12 Dec 1998)
peptide chain initiation The process whereby the formation of a peptide chain is started. This process requires (1) the 30s subunit, (2) the mRNA coding for the polypeptide to be made, (3) met-trnai, (4) initiation factors, and (5) GTP.
(12 Dec 1998)
peptide chain termination The process whereby the last amino acid is added to a polypeptide. This termination is signaled by one of three termination triplets in the mRNA, immediately following the last amino acid codon.
(12 Dec 1998)
peptide deformylase <enzyme> Fms is a zinc-containing protein showing homologies with zinc aminopeptidases; its enzyme function resembles that of an aminopeptidase; has been sequenced; mol mass 19,207 da
Registry number: EC 3.4.11.-
Synonym: fms protein, fms gene product
(26 Jun 1999)
peptide elongation factors Protein factors uniquely required during the elongation phase of protein synthesis.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • brain truster
    Á¤Ã¥°í¹®
  • brain wave
    ³úÆÄ;¿µ°¨;¹¦¾È
  • brain work
    Á¤½Å³ëµ¿ÀÚ
  • electronic brain
    ÀüÀÚ µÎ³ú(ÀüÀÚ °è»ê±â µûÀ§)
  • mechanical brain
    Àΰø µÎ³ú 
  • minimal brain dysfunction
    ¹Ì¼Ò ³ú±â´É Àå¾Ö (¾Æµ¿ÀÇ ÇнÀ Àå¾ÖÀÇ Çϳª)
  • right-brain
    ¿ì³ú
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á